Biotech Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update August 12, 2026
Biotech Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study August 12, 2026
Biotech Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones August 12, 2026
Biotech Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement August 12, 2026
Biotech Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights August 11, 2026
Biotech Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress August 10, 2026
Biotech Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027 August 10, 2026
Biotech Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company August 10, 2026
Biotech Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website August 6, 2026
Search
Biotech
August 12, 2026
August 12, 2026
August 12, 2026
August 12, 2026
August 11, 2026
August 11, 2026
August 10, 2026
August 10, 2026
August 10, 2026
August 6, 2026
